Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Berchuck

Showing results (161-170 of 191) with videos related to

Pageof 20
Sort By:
Human Pathology|November 1, 1996
Expression of the 67-kD laminin receptor, galectin-1, and galectin-3 in advanced human uterine adenocarcinomaF A van den Brule, C Buicu, A Berchuck, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 1993
Intraperitoneal cisplatin and regional hyperthermia for ovarian carcinomaK A Leopold, J R Oleson, D Clarke-Pearson, et al.
Journal of the National Cancer Institute|December 12, 1992
Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivationI J Jacobs, M F Kohler, R W Wiseman, et al.
Gynecologic Oncology|February 1, 1994
Overexpression of p53 is not a feature of benign and early-stage borderline epithelial ovarian tumorsA Berchuck, M F Kohler, M P Hopkins, et al.
Cancer|April 1, 1994
OVX1 as a marker for early stage endometrial carcinomaF J Xu, Y H Yu, L Daly, et al.
Cancer Research|October 18, 2000
An approach to analysis of large-scale correlations between genome changes and clinical endpoints in ovarian cancerS Suzuki, D H Moore, D G Ginzinger, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|June 1, 1996
BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cellsJ P Vaughn, P L Davis, M D Jarboe, et al.
Cancer|November 1, 1995
Soluble interleukin-2 receptor alpha is elevated in sera of patients with benign ovarian neoplasms and epithelial ovarian cancerJ A Hurteau, R P Woolas, I J Jacobs, et al.
Journal of the National Cancer Institute|November 3, 1993
Elevation of multiple serum markers in patients with stage I ovarian cancerR P Woolas, F J Xu, I J Jacobs, et al.
Cancer|May 1, 1994
Multivariable analysis of DNA ploidy, p53, and HER-2/neu as prognostic factors in endometrial cancerA S Lukes, M F Kohler, C F Pieper, et al.
Pageof 20

Showing results (161-170 of 191) with videos related to

Sort By:
Pageof 20
Human Pathology|November 1, 1996
Expression of the 67-kD laminin receptor, galectin-1, and galectin-3 in advanced human uterine adenocarcinomaF A van den Brule, C Buicu, A Berchuck, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 1993
Intraperitoneal cisplatin and regional hyperthermia for ovarian carcinomaK A Leopold, J R Oleson, D Clarke-Pearson, et al.
Journal of the National Cancer Institute|December 12, 1992
Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivationI J Jacobs, M F Kohler, R W Wiseman, et al.
Gynecologic Oncology|February 1, 1994
Overexpression of p53 is not a feature of benign and early-stage borderline epithelial ovarian tumorsA Berchuck, M F Kohler, M P Hopkins, et al.
Cancer|April 1, 1994
OVX1 as a marker for early stage endometrial carcinomaF J Xu, Y H Yu, L Daly, et al.
Cancer Research|October 18, 2000
An approach to analysis of large-scale correlations between genome changes and clinical endpoints in ovarian cancerS Suzuki, D H Moore, D G Ginzinger, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|June 1, 1996
BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cellsJ P Vaughn, P L Davis, M D Jarboe, et al.
Cancer|November 1, 1995
Soluble interleukin-2 receptor alpha is elevated in sera of patients with benign ovarian neoplasms and epithelial ovarian cancerJ A Hurteau, R P Woolas, I J Jacobs, et al.
Journal of the National Cancer Institute|November 3, 1993
Elevation of multiple serum markers in patients with stage I ovarian cancerR P Woolas, F J Xu, I J Jacobs, et al.
Cancer|May 1, 1994
Multivariable analysis of DNA ploidy, p53, and HER-2/neu as prognostic factors in endometrial cancerA S Lukes, M F Kohler, C F Pieper, et al.
Pageof 20